Application of β-cryptoxanthin helps to inhibit the recruitment of CD4+ and CD8+ T cells in the liver, attenuate insulin resistance and excessive lipid accumulation and peroxidation in the liver, and ultimately prevent or reverse inflammation and fibrosis in MASH (Ni et al., 2015a). The gene discussed is CD4; the disease is metabolic dysfunction-associated steatohepatitis.